We are currently experiencing a service degradation affecting customer login on our eShop platform in China. Our teams are actively working to resolve the issue and restore full functionality as soon as possible. If you encounter login difficulties, we recommend retrying after a short while. We appreciate your patience and understanding.

FectoVIR®-LV

Tech Support Documents
FectoVIR®-LV
 

FectoVIR®-LV is the next generation of transfection reagent, free of animal component, designed to improve LV productivity in HEK-293 cells and made for large scale manufacturing with reduction of the complexation volume and increased complex stability. FectoVIR®-LV benefits allow to increase number of doses produced per batch to treat more patient, while decreasing LV manufacturing costs.

Amount of Reagent
Item No.: 
101000189
*Custom/bulk order quotes are provided within 72 hours of request.
FectoVIR®-LV
FectoVIR®-LV

FectoVIR®-LV is the next generation of transfection reagent, free of animal component, designed to improve LV productivity in HEK-293 cells and made for large scale manufacturing with reduction of the complexation volume and increased complex stability. FectoVIR®-LV benefits allow to increase number of doses produced per batch to treat more patient, while decreasing LV manufacturing costs.

Item No.:
101000189

Overview

Specifications

Choose your Transfection For Viral Vector Manufacturing

See more products

Lentiviral vectors are recognized to be the carrier of choice for allogenic or autologous cell therapies (such as CAR-T) because of its capacity to permanently integrate viral genome into host cell DNA. To produce those vectors, cell therapy producers generally use a transient transfection system that is scaled-up during process development phases. FectoVIR®-LV is the next generation of transfection reagent, free of animal component, designed to improve LV productivity in HEK-293 cell systems. FectoVIR®-LV is made for large scale manufacturing with reduction of the complexation volume and increased complex stability. The FectoVIR®-LV benefits allow to increase number of doses produced per batch to treat more patient, while decreasing LV manufacturing costs. 

Take advantage of the complementary DOE service to fast-track optimization of lentivirus production with FectoVIR®-LV. 

Key Benefits:

    Productivity: Reach the highest Lentiviral vectors titers in suspension systems.
    Cost-Effectiveness: Reduce your cost per batch with high titers and low DNA consumption.
    Scalability: Produce at large scale with low complexation volume and long complex stability.
    Time-Saving: Use DOE service to help you optimizing your process in a record time.

Applications

  • Application
    Lentiviral vectors (LV) manufacturing using HEK-293 derivative cells cultivated in suspension

Biological Information

  • Number of transfections
    100 mL of FectoVIR®-LV transfection reagent is sufficient to transfect on average 50 L of cell culture (using standard conditions)

Compliance Information

  • Product Documentation
    • Protocol 
    • Certificate of Analysis 
    • Non-hazardous product statement
    • Certificate of origin 

General Specifications

  • Amount of Reagent
    FectoVIR®-LV 100 mL

Storage Conditions

  • Storage Conditions
    5 °C ± 3 °C